Craig-Hallum Keeps Their Buy Rating on Aspen Aerogels (ASPN)
Craig-Hallum Reaffirms Their Buy Rating on Aspen Aerogels (ASPN)
Optimistic Buy Rating for Insmed's Brensocatib Based on Forthcoming ASPEN Data and Competitive Analysis
What 12 Analyst Ratings Have To Say About Aspen Aerogels
Aspen Technology Analyst Ratings
Seaport Global Securities Raises Aspen Aerogels Price Target to $38 From $31, Maintains Buy Rating
Aspen Aerogels Analyst Ratings
Roth MKM Reiterates Buy on Aspen Aerogels, Raises Price Target to $36
Aspen Aerogels Analyst Ratings
Aspen Aerogels Analyst Ratings
Analysts Offer Insights on Industrial Goods Companies: Terran Orbital Corp (LLAP), Bluelinx Holdings (BXC) and Aspen Aerogels (ASPN)
Truist Securities Adjusts Price Target on Insmed to $68 From $48 After Positive ASPEN Results, Maintains Buy Rating
Insmed's Promising Future: A Buy Rating With Increased Price Target Post-ASPEN Trial Success
Buy Rating on Insmed With Increased Price Target Following Successful Phase 3 ASPEN Study of Brensocatib
Aspen Technology Analyst Ratings
Berenberg Upgrades Aspen Technology to Buy From Hold, Raises Price Target to $255 From $185, Says Overhangs Have Been Removed
Aspen Technology Analyst Ratings
Aspen Aerogels Analyst Ratings
Buy Rating Affirmed for Insmed on Strong TPIP Trial Results and High Anticipation for ASPEN Trial Outcomes
Baird Adjusts Price Target on Aspen Technology to $210 From $225, Keeps Outperform Rating
No Data